SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Activity
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

26 hedge funds and large institutions have $6.01M invested in Seelos Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
5
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$2.48M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$620K
3
BlackRock
3
BlackRock
New York
$150K
4
Franklin Resources
4
Franklin Resources
California
$137K
5
Citigroup
5
Citigroup
New York
$3K

Top Sellers

1
ARTA
1
A.R.T. Advisors
New York
$0
2
TSS
2
Two Sigma Securities
New York
$0
3
UBS Group
3
UBS Group
Switzerland
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$23K
5
Bank of America
5
Bank of America
North Carolina
$0
Name Market Value Shares Shares
Change 		Shares
Change %
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$0 100 – –
IA
27
IFP Advisors
Florida
$0 6 – –
SIAP
28
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$0 4 – –
BCM
29
Blume Capital Management
California
$0 3 – –
KF
30
Krilogy Financial
Missouri
$0 150 – –
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$0 8 +2 +33%
1
2